SELLAS Life Sciences (SLS) Other Non-Current Assets (2019 - 2024)

SELLAS Life Sciences (SLS) has disclosed Other Non-Current Assets for 9 consecutive years, with $43000.0 as the latest value for Q3 2024.

  • Quarterly Other Non-Current Assets fell 88.59% to $43000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $43000.0 through Sep 2024, down 88.59% year-over-year, with the annual reading at $275000.0 for FY2023, 31.08% down from the prior year.
  • Other Non-Current Assets for Q3 2024 was $43000.0 at SELLAS Life Sciences, down from $270000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $687000.0 in Q2 2020, with the low at $43000.0 in Q3 2024.
  • Average Other Non-Current Assets over 5 years is $470052.6, with a median of $514000.0 recorded in 2022.
  • The sharpest move saw Other Non-Current Assets skyrocketed 502.63% in 2020, then tumbled 88.59% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $614000.0 in 2020, then decreased by 3.26% to $594000.0 in 2021, then plummeted by 32.83% to $399000.0 in 2022, then plummeted by 31.08% to $275000.0 in 2023, then tumbled by 84.36% to $43000.0 in 2024.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $43000.0, $270000.0, and $272000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.